<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3914871</article-id><article-id pub-id-type="pmid">24505369</article-id><article-id pub-id-type="publisher-id">PONE-D-13-35855</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0088040</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Genetics</subject><subj-group><subject>Population Genetics</subject><subj-group><subject>Genetic Polymorphism</subject></subj-group></subj-group><subj-group><subject>Human Genetics</subject></subj-group></subj-group><subj-group><subject>Genomics</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Clinical Genetics</subject></subj-group><subj-group><subject>Non-Clinical Medicine</subject><subj-group><subject>Health Care Policy</subject><subj-group><subject>Health Risk Analysis</subject></subj-group></subj-group></subj-group><subj-group><subject>Oncology</subject><subj-group><subject>Cancer Risk Factors</subject><subj-group><subject>Genetic Causes of Cancer</subject></subj-group></subj-group><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Gastrointestinal Tumors</subject><subj-group><subject>Gastric Cancer</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Matrix Metalloproteinase-1 (MMP-1) Promoter Polymorphisms are Well Linked with Lower Stomach Tumor Formation in Eastern Indian Population </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">Association of MMP1 SNPs with Lower Stomach Cancer</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dey</surname><given-names>Sanjib</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ghosh</surname><given-names>Nillu</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Saha</surname><given-names>Debjit</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kesh</surname><given-names>Kousik</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Arnab</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Swarnakar</surname><given-names>Snehasikta</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Drug Development Diagnostic and Biotechnology Division, Indian Institute of Chemical Biology, Kolkata, India</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Saroj Gupta Cancer Center and Research Institute, Kolkata, India</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Naggar</surname><given-names>Redhwan Ahmed Al</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>Population Health and Preventive Medicine, Malaysia</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>snehasiktas@hotmail.com</email></corresp><fn fn-type="COI-statement"><p><text><SENT sid="1" pm="."><plain>Competing Interests: The authors have declared that no competing interests exist. </plain></SENT>
</text></p></fn><fn fn-type="con"><p><text><SENT sid="2" pm="."><plain>Conceived and designed the experiments: SS SD. </plain></SENT>
<SENT sid="3" pm="."><plain>Performed the experiments: SD NG KK DS. </plain></SENT>
<SENT sid="4" pm="."><plain>Analyzed the data: SS SD AG. </plain></SENT>
<SENT sid="5" pm="."><plain>Contributed reagents/materials/analysis tools: AG DS. </plain></SENT>
<SENT sid="6" pm="."><plain>Wrote the paper: SS SD NG KK. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>5</day><month>2</month><year>2014</year></pub-date><volume>9</volume><issue>2</issue><elocation-id>e88040</elocation-id><history><date date-type="received"><day>2</day><month>9</month><year>2013</year></date><date date-type="accepted"><day>3</day><month>1</month><year>2014</year></date></history><permissions><copyright-statement>© 2014 Dey et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Dey et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="7" pm="."><plain>Expression of matrix metalloproteinase-1 (MMP-1), an interstitial collagenase, plays a major role in cellular invasion during development of gastric cancer, a leading cause of death worldwide. </plain></SENT>
<SENT sid="8" pm="."><plain>A single-nucleotide polymorphism (SNP) −1607 1G/2G site of the MMP-1 gene promoter has been reported to alter transcription level. </plain></SENT>
<SENT sid="9" pm="."><plain>While the importance’s of other SNPs in the MMP-1 promoter have not yet been studied in gastric cancer, our aim was to investigate MMP-1 gene promoter polymorphisms and gastric cancer susceptibility in eastern Indian population. </plain></SENT>
<SENT sid="10" pm="."><plain>A total of 145 gastric cancer patients and 145 healthy controls were genotyped for MMP-1 −1607 1G/2G (rs1799750) by PCR-restriction fragment length polymorphism (RFLP), while MMP-1 −519 A/G (rs1144393), MMP-1 −422 T/A (rs475007), MMP-1 −340 T/C (rs514921) and MMP-1 −320 T/C (rs494379) were genotyped by DNA sequencing. </plain></SENT>
<SENT sid="11" pm="."><plain>A positive association was found with MMP-1 −422 T/A SNP that showed significant risk for regional lymph node metastasis (P = 0.021, Odd’s ratio (OR) = 3.044, Confidence intervals (CI) = 1.187–7.807). </plain></SENT>
<SENT sid="12" pm="."><plain>In addition, we found a significant association with lower stomach tumor formation among gastric cancer patients for three adjacent polymorphisms near the transcriptional start sites of [MMP-1 −422 T/A (P = 0.043, OR = 2.182, CI = 1.03–4.643), MMP-1 −340 T/C (P = 0.075, OR = 1.97, CI = 0.94–4.158) and MMP-1 −320 T/C (P = 0.034, OR = 2.224, CI = 1.064–40731)]. </plain></SENT>
<SENT sid="13" pm="."><plain>MMP-1 level in patients’ serum was correlated with MMP-1 promoter haplotypes conferring these three SNPs to evaluate the functional importance of these polymorphisms in lower stomach tumor formation and significant correlation was observed. </plain></SENT>
<SENT sid="14" pm="."><plain>Furthermore, MMP-1 −519 A/G polymorphism displayed poor cellular differentiation (P = 0.024, OR = 3.8, CI = 1.69–8.56) attributing a higher risk of cancer progression. </plain></SENT>
<SENT sid="15" pm="."><plain>In conclusion, MMP-1 proximal promoter SNPs are associated with the risk of lower stomach tumor formation and node metastasis in eastern Indian population. </plain></SENT>
</text></SecTag></p></abstract><funding-group><funding-statement>Sanjib Dey was recipient of Senior Research Fellowship from Indian Council of Medical Research (ICMR), India. NG and KK are recipient of Senior Research Fellowship from Council of Scientific and Industrial Research (CSIR). The work was supported by grant IAP001 of Council of Scientific and Industrial Research (CSIR), India, NBA07 of Department of Biotechnology (DBT), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="12"/></counts></article-meta></front><body><SecTag type="INTRO"><sec id="s1"><title><text><SENT sid="16" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="17" pm="."><plain>Gastric cancer is one of the leading causes of cancer related death in the world [1]. </plain></SENT>
<SENT sid="18" pm="."><plain>On a global scale, gastric cancer (GC) accounts for approximately 800,000 deaths annually. </plain></SENT>
<SENT sid="19" pm="."><plain>More than 70% of GC cases occur in developing countries and half the world total occurs in Eastern Asia [1]. </plain></SENT>
<SENT sid="20" pm="."><plain>It is a leading problem in north-eastern and southern states of the Indian subcontinent [2]. </plain></SENT>
<SENT sid="21" pm="."><plain>The incidence of gastric cancer varies from country to country, probably as a result of genetic, epigenetic and environmental factors. Helicobacter pylori infection is considered as a major risk factor in the development of gastric cancer especially cancer in the lower part (noncardia) of the stomach [3]. </plain></SENT>
<SENT sid="22" pm="."><plain>A combined analysis of 12 studies of H. pylori and gastric cancer estimated that the risk of adenocarcinoma in non-cardia regions of the stomach was nearly six times higher for H. pylori-infected people than for uninfected people [3]. </plain></SENT>
</text></p><p><text><SENT sid="23" pm="."><plain>Recent studies demonstrate that, carcinogenesis is a multi-cellular and multi-stage process in which destruction of the tissue microenvironment is a requisite for conversion of normal tissue to tumor [4]. </plain></SENT>
<SENT sid="24" pm="."><plain>Hence, molecular analysis of the tissue microenvironment and its deregulation during neoplasia is a key step to know the mechanisms of malignancy. </plain></SENT>
<SENT sid="25" pm="."><plain>Matrix metalloproteinases (MMPs), produced by both tumor and normal cells, alter the microenvironment by degrading extracellular matrix, and subsequent cellular signals lead to the early stages of tumor formation [5]. </plain></SENT>
<SENT sid="26" pm="."><plain>Several of the MMPs have the unique ability to degrade the interstitial collagens (e.g. I, II, and III), the body's most abundant proteins. </plain></SENT>
<SENT sid="27" pm="."><plain>MMP-1 is the most ubiquitously expressed interstitial collagenase [6] and its overexpression is associated with several pathological conditions, including tumor invasion and metastasis [7]. </plain></SENT>
<SENT sid="28" pm="."><plain>The overexpression of MMP-1 mRNA has been demonstrated in a variety of cancers such as gastric cancer, colorectal cancer and esophageal cancer [8]–[12]. </plain></SENT>
<SENT sid="29" pm="."><plain>Overexpression of MMP-1 protein is associated with poor prognosis of esophageal cancer and colorectal cancer [10], [11]. </plain></SENT>
<SENT sid="30" pm="."><plain>This MMP-1 overexpression may be attributed to the juxtaposition of transcription factor binding sites and cooperativity among the factors that bind to these sites within the promoter region of the MMP-1 gene [13]. </plain></SENT>
</text></p><p><text><SENT sid="31" pm="."><plain>The promoter region of MMP-1 contains a guanine insertion/deletion polymorphism (1G/2G polymorphism) at position −1607 which generates the sequence 5′-GGA-3′ which has a 2G allele. </plain></SENT>
<SENT sid="32" pm="."><plain>The presence of a 2G polymorphism could increase transcriptional activity of endogenous MMP-1 because the guanine insertion creates a binding site for a member of the Ets transcription factor family. </plain></SENT>
<SENT sid="33" pm="."><plain>The 2G allele may contribute to increased invasiveness of endometrial carcinomas, to the development of ovarian cancer, lung cancer, and colorectal cancer [14]–[21]. </plain></SENT>
</text></p><p><text><SENT sid="34" pm="."><plain>Studies in several other genes have provided a new paradigm in which the transcription of a gene is more likely to be influenced by multiple polymorphisms located in the promoter region which act in concert to exert a haplotype effect [22], [23]. </plain></SENT>
<SENT sid="35" pm="."><plain>Several other single nucleotide polymorphisms (−519A/G, −422T/A, −340C/T, and −320C/T) in the MMP-1 gene promoter have recently been identified [24]. </plain></SENT>
<SENT sid="36" pm="."><plain>Functional effects of these polymorphisms on the MMP-1 gene promoter activity were assessed in cell lines of melanoma (A2058 and A375), breast cancer (MCF7 and MDA-MB-231), lung cancer (A549 and H69), and colorectal cancer (HT-29, SW-620) by comparing the promoter strengths of the 10 most common haplotypes derived from these polymorphisms [24]. </plain></SENT>
<SENT sid="37" pm="."><plain>Although the enhanced expression of MMP-1 was associated with local invasion and poor prognosis in gastric cancer [25], the role of the MMP-1 promoter SNPs and their haplotypes in the development of gastric cancer is currently unknown in any human population. </plain></SENT>
</text></p><p><text><SENT sid="38" pm="."><plain>In the present study, we conducted a hospital-based case-control study to explore the association of the MMP-1 gene promoter SNPs [−1607 1G/2G (rs1799750) (MMP-1.1), −519A/G (rs1144393) (MMP-1.2), −422T/A (rs475007) (MMP-1.3), −340C/T (rs514921) (MMP-1.4), and −320C/T (rs494379) (MMP-1.5)] and their haplotypes with the risk of gastric cancer development in an eastern Indian population. </plain></SENT>
<SENT sid="39" pm="."><plain>We also explored the relationship between the polymorphisms and the clinicopathological factors among gastric cancer patients. </plain></SENT>
<SENT sid="40" pm="."><plain>The study demonstrated the putative association of MMP-1.3, MMP-1.4, and MMP-1.5 polymorphisms with the risk of lower stomach tumor formation in gastric cancer. </plain></SENT>
<SENT sid="41" pm="."><plain>The functional importance of MMP-1 polymorphisms in lower stomach tumor formation was confirmed by haplotype effects of these polymorphisms on MMP-1 expression levels in serum. </plain></SENT>
<SENT sid="42" pm="."><plain>However, no association with the occurrence of gastric cancer was found for any of the above five SNPs of the MMP-1 promoter and their resultant haplotypes. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="s2"><title><text><SENT sid="43" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><sec id="s2a"><title><text><SENT sid="44" pm="."><plain>Study Subjects: Eastern Indian Case-control Cohort </plain></SENT>
</text></title><p><text><SENT sid="45" pm="."><plain>The eastern Indian case-control cohort consisted of 145 gastric cancer cases and 145 control individuals. </plain></SENT>
<SENT sid="46" pm="."><plain>The study protocols (2008–2014) were approved by the Ethical Review Boards of the Saroj Gupta Cancer Center and Research Institute, Kolkata, Department of Gastric Surgery, Medical College and Hospital, Kolkata, IPGMER, Kolkata hospitals and the Human Ethics Committee of the Indian Institute of Chemical Biology, Kolkata, India. </plain></SENT>
<SENT sid="47" pm="."><plain>All patients with a clinical diagnosis of gastric cancer attending the hospital Departments of Gastro-oncology of the Saroj Gupta Cancer Center and Research Institute, Kolkata, the Department of Gastric Surgery, Medical College and Hospital, Kolkata and the IPGMER, Kolkata during June 2008 to May 2013 were identified from hospital registries and contacted during follow up investigations. </plain></SENT>
<SENT sid="48" pm="."><plain>All participants gave written informed consent for participation. </plain></SENT>
<SENT sid="49" pm="."><plain>Patients’ demographics, symptoms and tumor grading were recorded and blood samples collected after taking a clinical history and performing clinical and endoscopic examinations. </plain></SENT>
<SENT sid="50" pm="."><plain>Histological tumor typing was determined on the basis of biopsies or resected specimens. </plain></SENT>
<SENT sid="51" pm="."><plain>The exclusion criteria included previous history of other metastasized cancer except gastric cancer. </plain></SENT>
<SENT sid="52" pm="."><plain>Possibility of peptic ulcer without having any cancerous lesion had been excluded by histopathology of stomach lesion. </plain></SENT>
<SENT sid="53" pm="."><plain>The diagnosis of gastric cancer and TNM staging was based on generally accepted clinical, histological, radiological and immunofluorescence findings and that of the American Joint Committee on cancer (AJCC) and the International Union Against Cancer (UICC) criterion [25]. </plain></SENT>
<SENT sid="54" pm="."><plain>Individuals who were formerly or who currently have been addicted to tobacco for at least 2 years were defined as tobacco addicted. </plain></SENT>
<SENT sid="55" pm="."><plain>Persons visiting these hospitals for a routine checkup and who were without a history or diagnosis of any cancer or genetic diseases were also asked to participate and volunteer to donate blood for the study. </plain></SENT>
<SENT sid="56" pm="."><plain>These subjects were considered healthy controls. </plain></SENT>
<SENT sid="57" pm="."><plain>All of the cancer patients and control subjects were unrelated and of Indian nationality from West Bengal or the surrounding eastern Indian states. </plain></SENT>
<SENT sid="58" pm="."><plain>This population was considered representative of an eastern Indian population. </plain></SENT>
</text></p></sec><sec id="s2b"><title><text><SENT sid="59" pm="."><plain>DNA Extraction and Serum Collection </plain></SENT>
</text></title><p><text><SENT sid="60" pm="."><plain>From each subject, 5 ml of venous blood were drawn aseptically into vacutainer tubes (Qiagen, USA) containing EDTA and stored at 4°C prior to genomic DNA extraction. </plain></SENT>
<SENT sid="61" pm="."><plain>Genomic DNA was extracted from 3.5 ml of whole-blood within two weeks following sampling using a QIAamp DNA Blood Midi Kit (Qiagen, USA) according to the manufacturer’s protocol. </plain></SENT>
<SENT sid="62" pm="."><plain>Immediately following blood collection, additional1.5 ml of whole blood was centrifuged at 1800 g for 5 min to obtain the serum fraction. </plain></SENT>
<SENT sid="63" pm="."><plain>Serum samples were stored at −80°C until analysis. </plain></SENT>
</text></p></sec><sec id="s2c"><title><text><SENT sid="64" pm="."><plain>Primers and PCR Amplification of the Promoter Region of MMP-1 Genes </plain></SENT>
</text></title><p><text><SENT sid="65" pm="."><plain>Primers were designed with FastPCR software (<ext-link ext-link-type="uri" xlink:href="http://www.biocenter.helsinki.fi">http://www.biocenter.helsinki.fi</ext-link>) so as to amplify promoter regions of the MMP-1 gene in order to analyze polymorphisms by sequencing (Table 1). </plain></SENT>
<SENT sid="66" pm="."><plain>PCR was performed in a PCR SPRINT Thermal Cycler (Thermo Electron Corporation, Japan). </plain></SENT>
<SENT sid="67" pm="."><plain>The target sequence was amplified in a 25-µl reaction volume containing 10–20 ng of genomic DNA, 0.2 mM dNTP, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2 mM MgCl2, 0.3 µM of each primer, and 1.0 units of Taq DNA polymerase (Fermentas Taq DNA polymerase, Fermentas, USA). </plain></SENT>
<SENT sid="68" pm="."><plain>The PCR amplification was carried out with 35 cycles of denaturation at 94°C for 30 s, annealing at 58°C-59°C for 1 min (Table 1) and followed by extension at 72°C for 30 s after the initial activation step of 94°C for 5 min. </plain></SENT>
<SENT sid="69" pm="."><plain>PCR fragments were analyzed comparing with 100 bp DNA ladder (Fermentas, USA) on an ethidium bromide stained 1.5% agarose gel (Cat No. 014011, Sisco Research Laboratories, India) run for 60 min at 100 V. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0088040-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0088040.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="70" pm="."><plain>PCR primers used for polymorphism analysis. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0088040-t001-1" xlink:href="pone.0088040.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="71" pm="."><plain>Polymorphisms </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="72" pm="."><plain>Primer sequence (5′-3′) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="73" pm="."><plain>Ta (°C) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="74" pm="."><plain>Product size </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="75" pm="."><plain>Screening method used </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="76" pm="."><plain>MMP-1 −1607 1G/2G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="77" pm="."><plain>ACATTGCAGGATGTGCAGGCTCTT (F) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="78" pm="."><plain>58 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="79" pm="."><plain>782 bp </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="80" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="81" pm="."><plain>CTTGGGTACTGGTGACCGGTGTCA (R) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="82" pm="."><plain>MMP-1 −1607 1G/2G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="83" pm="."><plain>TGACTTTTAAAACATAGTCTATGTTCA (F) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="84" pm="."><plain>58.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="85" pm="."><plain>269 bp </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="86" pm="."><plain>PCR-RFLP </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="87" pm="."><plain>TCTTGGATTGATTTGAGATAAGTCATAGC (R) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>MMP 1 −519 A/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain>TACAGGTGCATGACTCCATGCTTG (F) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>58 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>885 bp </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>TCTAGAGTCGCTGGGAAGCTGTGA (R) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>MMP-1 −422 T/A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>TACAGGTGCATGACTCCATGCTTG (F) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>58 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>885 bp </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="99" pm="."><plain>TCTAGAGTCGCTGGGAAGCTGTGA (R) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="100" pm="."><plain>MMP-1 −340 T/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="101" pm="."><plain>TACAGGTGCATGACTCCATGCTTG (F) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain>58 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="103" pm="."><plain>885 bp </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="104" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="105" pm="."><plain>TCTAGAGTCGCTGGGAAGCTGTGA (R) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="106" pm="."><plain>MMP-1 −320 T/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="107" pm="."><plain>TACAGGTGCATGACTCCATGCTTG (F) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="108" pm="."><plain>58 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="109" pm="."><plain>885 bp </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="110" pm="."><plain>Sequencing </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="111" pm="."><plain>TCTAGAGTCGCTGGGAAGCTGTGA (R) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives></table-wrap></SecTag></sec><sec id="s2d"><title><text><SENT sid="112" pm="."><plain>Genotyping </plain></SENT>
</text></title><p><text><SENT sid="113" pm="."><plain>For genotyping by sequencing, any unincorporated dNTPs were dephosphorylated and unincorporated primers were removed from the PCR product by shrimp alkaline phosphatase (Fermentas, USA) and exonuclease-I enzyme (Fermentas, USA). </plain></SENT>
<SENT sid="114" pm="."><plain>PCR products were used for sequencing with BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, USA) and sequenced using a ABI PRISM 3100 genetic analyzer (Perkin-Elmer ABI, Foster City, Calif.) according to the manufacturer’s protocol. </plain></SENT>
<SENT sid="115" pm="."><plain>The PCR amplicon was sequenced in both directions with forward and reverse PCR primers eliminating the possibility of compression artifacts. </plain></SENT>
<SENT sid="116" pm="."><plain>Sequencing chromatograms were analyzed using Sequence Scanner Software v1.0 (Applied Biosystems, USA) to analyze alterations of the nucleotides and thus genotypes. </plain></SENT>
</text></p><p><text><SENT sid="117" pm="."><plain>The MMP-1.1 1G/2G polymorphism was genotyped by PCR- restriction fragment length polymorphism (RFLP) method using AluI enzyme (New England BioLabs, Inc. </plain></SENT>
<SENT sid="118" pm="."><plain>(NEB); Ipswich, MA), as described previously [26]. </plain></SENT>
</text></p></sec><sec id="s2e"><title><text><SENT sid="119" pm="."><plain>Enzyme-Linked Immunosorbent Assay (ELISA) </plain></SENT>
</text></title><p><text><SENT sid="120" pm="."><plain>Serum MMP-1 protein level (pro and active) in patients with upper stomach cancer with non risk haplotypes, and in lower stomach cancer with risk haplotypes (contains one or more risk alleles) were compared using a commercially available MMP-1 ELISA kit (ab10063, Abcam, USA), according to the manufacturer’s instruction. </plain></SENT>
<SENT sid="121" pm="."><plain>Serum samples were diluted (1∶5 v/v) in assay diluent provided in the kit. </plain></SENT>
<SENT sid="122" pm="."><plain>Briefly, 100 µl of the standards, blanks and diluted serum sample were pipetted into the anti-human MMP-1 precoated 96-well plate provided within the kit and incubated for 2.5 hours at 37°C. </plain></SENT>
<SENT sid="123" pm="."><plain>After several washes, biotinylated anti-human MMP-1 antibody (diluted 1∶1000) was added to the wells and the plate was incubated for 1 hour at room temperature. </plain></SENT>
<SENT sid="124" pm="."><plain>After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is pipetted to the wells. </plain></SENT>
<SENT sid="125" pm="."><plain>The plate was again incubated for 45 min. </plain></SENT>
<SENT sid="126" pm="."><plain>After extensive washing, 100 µl of the substrate tetramethylbenizidine was pipette into each well, and the plate was incubated for 30 min in the dark at room temperature (25°C). </plain></SENT>
<SENT sid="127" pm="."><plain>A stop solution was added upon completion. </plain></SENT>
<SENT sid="128" pm="."><plain>Each sample was tested in duplicate. </plain></SENT>
<SENT sid="129" pm="."><plain>The absorbance values of the blanks, samples, and standards were read on a microplate reader at a wavelength of 450 nm. </plain></SENT>
<SENT sid="130" pm="."><plain>The level of MMP-1 protein in the samples was obtained by comparison with the standard curve, generated from standard supplied by the manufacture. </plain></SENT>
<SENT sid="131" pm="."><plain>The minimum detectable level of MMP 1 was 8 pg/ml. </plain></SENT>
</text></p></sec><sec id="s2f"><title><text><SENT sid="132" pm="."><plain>Statistical Analysis </plain></SENT>
</text></title><p><text><SENT sid="133" pm="."><plain>Statistical analysis was performed using the SPSS software (version 16.0J. </plain></SENT>
<SENT sid="134" pm="."><plain>SPSS, Inc., Chicago, IL, USA). </plain></SENT>
<SENT sid="135" pm="."><plain>Significant differences between age at interview for controls and age at diagnosis for cancer cases were assessed using the Student’s t-test for comparison of means using GraphPad InStat3 software (GraphPad Software, Inc., San Diego California USA). </plain></SENT>
<SENT sid="136" pm="."><plain>Hardy–Weinberg equilibrium (HWE) analyses were performed to compare observed and expected allele frequencies using a chi-square test for controls to ensure that each marker was in equilibrium (p&gt;0.05). </plain></SENT>
<SENT sid="137" pm="."><plain>The minor allele frequency (MAF) (–model option) and HWE (–hardy option) for each SNP was estimated from the control population using Plink v0.99 [27]. </plain></SENT>
<SENT sid="138" pm="."><plain>Case-control data were analyzed using two-sided 2-by-2 or 2-by-3 contingency tables according to the genotype by the Pearson chi-square test. </plain></SENT>
<SENT sid="139" pm="."><plain>The odds ratio (OR) and 95% confidence interval (CI) of the genotypes were calculated from a multivariate logistic regression model adjusted for age (continuous variable), sex and tobacco addiction. </plain></SENT>
<SENT sid="140" pm="."><plain>In this study, we defined that the 1G allele of the 1G-1607 2G SNP, the A allele of the A-519G SNP, the A allele of the T-422A SNP, the T allele of the T-340C SNP and the T allele of the T-320C SNP were reference alleles. </plain></SENT>
<SENT sid="141" pm="."><plain>The results were evaluated with above alleles as a reference using the multinomial logistic regression model. </plain></SENT>
<SENT sid="142" pm="."><plain>In analyzing the relationship between the SNP genotypes and disease status of GC, the stage of cancer, histological classification and depth of tumor invasion were transformed to binary data (Stage I+II vs. stage III+IV, well-differentiated+moderately-differentiated vs. Poorly-differentiated, and T1+T2 vs. T3+T4). </plain></SENT>
<SENT sid="143" pm="."><plain>The relationship between genotype distributions and tumor depth or stage was also examined using a multinomial logistic regression model adjusted for age (continuous variable), sex and tobacco addiction as a potential confounding factor. </plain></SENT>
<SENT sid="144" pm="."><plain>Haplotype frequencies were analyzed using the program Haploview (ver. 4.1, Broad Institute, Chembridge, USA) [28]. </plain></SENT>
<SENT sid="146" pm="."><plain>All results were considered statistically significant if the p value was &lt;0.05. </plain></SENT>
<SENT sid="147" pm="."><plain>A post hoc power calculation has been performed to test the statistical power of the present study according to the method of Schlesselman, JJ [29]. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec id="s3"><title><text><SENT sid="148" pm="."><plain>Results </plain></SENT>
</text></title><sec id="s3a"><title><text><SENT sid="149" pm="."><plain>Description of the Study Population </plain></SENT>
</text></title><p><text><SENT sid="150" pm="."><plain>The study population consisted of 145 gastric cancer patients having 112 (77.2%) males and 33 (22.8%) females with an age range of 42.6–65.8 years, as well as 145 control subjects having 81 (55.9%) males and 64 (44.1%) females with an age range of 34.5–62.5 years. </plain></SENT>
<SENT sid="151" pm="."><plain>Patients and control subjects were derived from the same geographic location and are representative of an eastern Indian population. </plain></SENT>
<SENT sid="152" pm="."><plain>There were statistically significant differences in the distribution of gender (p&lt;0.001) and age (p&lt;0.0001) between patients and controls. </plain></SENT>
<SENT sid="153" pm="."><plain>Also, significantly more tobacco-addicted individuals (p&lt;0.0001) were present among patients (68.3%) compared with controls (28.3%). </plain></SENT>
<SENT sid="154" pm="."><plain>So, in the course of risk estimation, an age, sex and addiction-adjusted Odds ratios were calculated. </plain></SENT>
</text></p></sec><sec id="s3b"><title><text><SENT sid="155" pm="."><plain>Detection of Single Nucleotide Polymorphisms in the MMP-1 Promoter </plain></SENT>
</text></title><p><text><SENT sid="156" pm="."><plain>Naturally occurring, common sequence variants of the MMP-1 gene promoter in cases and controls were searched by direct DNA sequencing. </plain></SENT>
<SENT sid="157" pm="."><plain>Alignment of sequence chromatogram with the MMP-1 gene promoter contig sequence (Genebank accession no- AF023338) confirmed the SNP positions at −1607 (1G/2G, i.e., G insertion/deletion), −519 (A/G), −422 (T/A), −340 (T/C) and −320 (T/C) (Figure S1 in File S1). </plain></SENT>
<SENT sid="158" pm="."><plain>MMP-1.1 genotyping by PCR-RFLP was then performed among the gastric cancer patients and controls. </plain></SENT>
<SENT sid="159" pm="."><plain>Figure S1A (File S1) shows a typical PCR-RFLP pattern. </plain></SENT>
<SENT sid="160" pm="."><plain>The 269 bp target region of the MMP-1 gene promoter was PCR-amplified and digested with AluI, which cleaved the 1G allele to generate two fragments of 241 bp and 28 bp. </plain></SENT>
<SENT sid="161" pm="."><plain>The 2G allele did not digest with AluI. </plain></SENT>
<SENT sid="162" pm="."><plain>Heterozygous genotype showed three bands of 269 bp, 241 bp and 28 bp (Figure S1A in File S1). </plain></SENT>
<SENT sid="163" pm="."><plain>MMP-1.2, MMP-1.3, MMP-1.4) and MMP-1.5 were genotyped by DNA sequencing (Figure S1B in File S1). </plain></SENT>
<SENT sid="164" pm="."><plain>The MMP-1.1 genotype analysis by DNA sequencing was restricted to a pilot study as well as for 10% of the population for rechecking. </plain></SENT>
<SENT sid="165" pm="."><plain>All genotyping was performed among 145 patients and 145 controls. </plain></SENT>
</text></p></sec><sec id="s3c"><title><text><SENT sid="166" pm="."><plain>Association between Individual SNPs of MMP-1 Promoter and Gastric Cancer Risk </plain></SENT>
</text></title><p><text><SENT sid="167" pm="."><plain>The genotype distributions of MMP-1 polymorphisms were consistent with the Hardy–Weinberg equilibrium (HWE). </plain></SENT>
<SENT sid="168" pm="."><plain>The study would have reached a power of 80% (Z-alpha = 1.645, for alpha = 0.05) with 145 cases, case control ratio of 1.0 and 10% exposed control to the risk allele having OR of 2.31. </plain></SENT>
</text></p><p><text><SENT sid="169" pm="."><plain>MMP-1.1 polymorphism showed no significant difference in distribution of genotypes (1G1G vs. 1G2G, 2G2G and 1G2G+2G2G) between patients and controls (p = 0.430, p = 0.465 and p = 0.411 respectively). </plain></SENT>
<SENT sid="170" pm="."><plain>Also, the allele frequency distribution (1G vs. 2G) was not significant between patients and controls (p = 1.000), and thus did not confer any risk for gastric cancer development (Table 2). </plain></SENT>
<SENT sid="171" pm="."><plain>It is also noteworthy that the 2G allele was the major allele in this population and we took it as a risk allele as many other studies have previously considered it a risk allele [14], [30], [31]. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0088040-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0088040.t002</object-id><label>Table 2</label><caption><title><text><SENT sid="172" pm="."><plain>Analysis of association between MMP-1 SNPs and the risk of occurrence of gastric cancer. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0088040-t002-2" xlink:href="pone.0088040.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>Genotype </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="174" pm="."><plain>GC Patient </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="175" pm="."><plain>Controls </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>OR </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>95% CI </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>P value </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>n </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>% </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>N </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>% </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>MMP-1.1 (−1607 1G/2G) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain>145 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>145 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>1G1G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>23 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="188" pm="."><plain>15.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="189" pm="."><plain>20 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="190" pm="."><plain>13.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="191" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>1G2G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>66 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>45.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>72 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>49.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>0.742 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>0.353–1.559 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>0.430 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>2G2G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>56 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>38.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>53 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain>36.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="205" pm="."><plain>0.746 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>0.340–1.637 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="207" pm="."><plain>0.465 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="208" pm="."><plain>1G2G+2G2G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="209" pm="."><plain>122 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="210" pm="."><plain>84.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="211" pm="."><plain>125 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="212" pm="."><plain>86.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="213" pm="."><plain>0.742 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="214" pm="."><plain>0.364–1.511 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>0.411 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>1G allele </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>112 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>38.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>112 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="220" pm="."><plain>38.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="221" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="222" pm="."><plain>2G allele </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="223" pm="."><plain>178 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain>61.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>178 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>61.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>1.000 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>0.716–1.397 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>1.000 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>MMP-1.2 (−519 A/G) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>145 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>145 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>AA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>91 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>62.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>100 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>69.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>AG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>49 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>33.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>41 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>28.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>1.154 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>0.672–1.982 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>0.603 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>3.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>2.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>1.640 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>0.382–7.047 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>0.506 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>AG+GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>54 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>37.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>45 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>31.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>1.194 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>0.705–2.020 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>0.510 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>A allele </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>231 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>79.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>241 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>83.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>G allele </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>59 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>20.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>49 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>16.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>1.256 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>0.826–1.911 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>0.337 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>MMP-1.3 (−422 T/A) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>145 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>145 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>17 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>11.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>17 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>11.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>1.221 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>0.547–2.725 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>0.626 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>TA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>53 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>36.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>51 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>35.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>1.000 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="294" pm="."><plain>0.581–1.722 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>0.999 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>AA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>75 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="298" pm="."><plain>51.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="299" pm="."><plain>77 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="300" pm="."><plain>53.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="301" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="302" pm="."><plain>TA+TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>70 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>48.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>68 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>46.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>1.065 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>0.646–1.755 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>0.806 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>T allele </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>87 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>30 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>85 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>29.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>1.034 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>0.724–1.476 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>0.927 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>A allele </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>203 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>70 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>205 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>70.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>MMP-1.4 (−340 T/C) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>145 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>145 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>69 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>47.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>78 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>53.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>TC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>64 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>44.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>57 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>39.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>1.209 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>0.719–2.032 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>0.474 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>8.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>6.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>1.499 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>0.556–4.043 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>0.424 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>TC+CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>76 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>52.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>67 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>46.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>1.246 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>0.757–2.051 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>0.388 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>T allele </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>202 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>69.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>213 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>73.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>C allele </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>88 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>30.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>77 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>26.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>1.205 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>0.839–1.73 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>0.357 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>MMP-1.5 (−320 T/C) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>145 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>145 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>73 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>50.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>67 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>46.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>TC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>61 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>42.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>64 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>44.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>0.769 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>0.454–1.303 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>0.329 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>7.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>9.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>0.650 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="394" pm="."><plain>0.259–1.631 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>0.358 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>TC+CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>72 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>49.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>74 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>53.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>0.734 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>0.443–1.214 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>0.228 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>T allele </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>207 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>71.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>198 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>69.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>C allele </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>83 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>28.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>92 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>31.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>0.863 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>0.605–1.231 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>0.469 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p><text><SENT sid="418" pm="."><plain>Adjusted OR calculated for age, sex and addiction, by binary logistic regression model using SPSS v16.0 software. </plain></SENT>
<SENT sid="419" pm="."><plain>P value is for χ2 test showing the significance of difference in the distributions of the genotypes and alleles between patients and controls. </plain></SENT>
<SENT sid="420" pm="."><plain>OR = Odds ratio, CI = Confidence Interval, Ref = Reference genotype or allele to calculate OR. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="421" pm="."><plain>In gastric cancer patients, the frequency of the MMP-1.2 AG, GG and AG+GG genotypes were not significantly different from healthy controls (p = 0.603, p = 0.506 and p = 0.510 respectively) and thus did not confer any significant risk for gastric cancer. </plain></SENT>
<SENT sid="422" pm="."><plain>Also, the allele frequency (A vs. G) in cancer patients were not significantly differed from healthy controls (p = 0.337) and did not confer risk for gastric cancer development (Table 2). </plain></SENT>
</text></p><p><text><SENT sid="423" pm="."><plain>The genotype frequency distribution, (AA vs. TT, TA and TA+TT) of the MMP-1.3 polymorphism in the patient population was not significantly different from healthy controls (p = 0.626, p = 0.999 and p = 0.806 respectively) and thus did not confer any significant risk for gastric cancer. </plain></SENT>
<SENT sid="424" pm="."><plain>Also, the allele frequency (T vs. A) distribution in cancer patients and controls were not significant (p = 0.927) (Table 2). </plain></SENT>
</text></p><p><text><SENT sid="425" pm="."><plain>For patient MMP-1.4 polymorphism, genotypes (TT vs. TC, CC and TC+CC) showed a similar distribution to that seen in controls (p = 0.474, p = 0.424 and p = 0.388 respectively) showing no association for gastric cancer risk. </plain></SENT>
<SENT sid="426" pm="."><plain>Also, the distribution of allele frequency (T vs. C) in patients and controls was not statistically different (p = 0.357), further showing the absence of any association with gastric cancer risk (Table 2). </plain></SENT>
</text></p><p><text><SENT sid="427" pm="."><plain>MMP-1.5 polymorphism genotype frequencies (TT vs. TC, CC and TC+CC) in patients was similarly distributed to that of controls (p = 0.329, p = 0.358 and p = 0.228 respectively) showing no significant risk for gastric cancer. </plain></SENT>
<SENT sid="428" pm="."><plain>Also, the distribution of allele frequency (T vs. C) in both patients and controls was not significantly different (p = 0.469) (Table 2). </plain></SENT>
</text></p></sec><sec id="s3d"><title><text><SENT sid="429" pm="."><plain>Association between Individual SNPs of MMP-1 as well as Demographic and Clinicopathological Features at the Time of Gastric Cancer Diagnosis </plain></SENT>
</text></title><p><text><SENT sid="430" pm="."><plain>Associations were examined between each polymorphism and the demographic and clinicopathological features of gastric cancer patients and controls (Table 3). </plain></SENT>
<SENT sid="431" pm="."><plain>MMP-1.1, MMP-1.2, MMP-1.3, MMP-1.4 and MMP-1.5 polymorphisms did not play any role in determining gastric cancer risk for any age group, gender or tobacco-addiction status. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0088040-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0088040.t003</object-id><label>Table 3</label><caption><title><text><SENT sid="432" pm="."><plain>Association between the genotypes of MMP-1 SNPs and clinicopathological characteristics of gastric cancer patients. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0088040-t003-3" xlink:href="pone.0088040.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1"><text><SENT sid="433" pm="."><plain>MMP-1.1(−1607 1G/2G), n (%) </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="434" pm="."><plain>MMP-1.2(−519 A/G), n (%) </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="435" pm="."><plain>MMP-1.3(−422 T/A), n (%) </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="436" pm="."><plain>MMP-1.4(−340 T/C), n (%) </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="437" pm="."><plain>MMP-1.5(−320 T/C), n (%) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>1G/1G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>1G/2G+2G/2G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>A/A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>A/G+G/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>A/A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>T/A+T/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>T/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>T/C+CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>T/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>T/C+CC </plain></SENT>
</text></td></tr></thead><tbody><tr><td colspan="11" align="left" rowspan="1"><text><SENT sid="448" pm="."><plain>Age (years) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>≥45 (Case/Cont) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>18/8 (15.0/11.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>102/65 (85.0/89.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>72/49 (60.0/67.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>48/24 (40.0/32.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>61/38 (50.8/52.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>59/35 (49.2/47.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>58/38 (48.3/52.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>62/35 (51.7/47.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>56/32 (46.7/43.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>64/41 (53.3/56.2) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>OR (95% CI) (a) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>0.77 (0.31–1.90) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="463" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>1.38 (0.75–2.55) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>1.116 (0.62–2.02) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>1.13(0.63–2.04) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>0.90 (0.50–1.62) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>&lt;45 (Case/Cont) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>5/12 (20.0/16.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>20/60 (80.0/83.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>19/51 (76.0/70.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>6/21 (24.0/29.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>14/39 (56.0/54.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>11/33 (44.0/45.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>11/40 (44.0/55.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>14/32 (56.0/44.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>17/35 (68.0/48.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>8/37 (32.0/51.4) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>OR (95% CI) (a) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>0.56 (0.16–1.97) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>0.78 (0.26–2.30) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>0.90 (0.35–2.33) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>1.62 (0.63–4.19) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>0.42 (0.16–1.14) </plain></SENT>
</text></td></tr><tr><td colspan="11" align="left" rowspan="1"><text><SENT sid="493" pm="."><plain>Gender </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>Male (Case/Cont) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>17/12 (15.2/14.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>95/69 (84.8/85.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>69/58 (61.6/71.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>43/23 (38.4/28.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>58/47 (51.8/58.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>54/34 (48.2/42.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>51/44 (45.5/54.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="502" pm="."><plain>61/37 (54.5/45.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>57/36 (50.9/44.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>55/45 (49.1/55.6) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>OR (95% CI) (b) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>1.07 (0.47–2.44) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>1.45 (0.77–2.74) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>1.32 (0.73–2.41) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>1.41 (0.78–2.55) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>0.69 (0.38–1.27) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>Female (Case/Cont) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>6/8 (18.2/12.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>27/56 (81.8/87.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>22/42 (66.7/65.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>11/22 (33.3/34.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>17/30 (51.5/46.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>16/34 (48.5/53.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>18/34 (54.5/53.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>15/30 (45.5/46.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>16/31 (48.5/48.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>17/33 (51.5/51.6) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="527" pm="."><plain>OR (95% CI) (b) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>0.18 (0.04–0.85) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>0.76 (0.29–2.02) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>0.60 (0.23–1.55) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>0.94 (0.38–2.37) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>0.83 (0.33–2.09) </plain></SENT>
</text></td></tr><tr><td colspan="11" align="left" rowspan="1"><text><SENT sid="538" pm="."><plain>Location of cancer </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>Lower stomach/Upper stomach </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>16/7 (18.0/15.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>73/38 (82.0/84.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>52/31 (58.4/68.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="543" pm="."><plain>37/14 (41.5/31.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>42/29(47.2/64.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>47/16 (52.8/35.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>37/26 (41.6/57.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>52/19 (58.4/42.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>37/28 (41.6/62.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>52/17 (58.4/37.8) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>OR (95% CI) (c) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="551" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="552" pm="."><plain>0.87 (0.33–2.31) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="553" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="554" pm="."><plain>1.73 (0.79–3.77) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="555" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="556" pm="."><plain>2.18 (1.03–4.64) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="557" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="558" pm="."><plain>1.97 (0.94–4.15) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="559" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="560" pm="."><plain>2.22 (1.06–4.07) </plain></SENT>
</text></td></tr><tr><td colspan="11" align="left" rowspan="1"><text><SENT sid="561" pm="."><plain>Tumor size </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="562" pm="."><plain>≥5 cm/&lt;5 cm </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="563" pm="."><plain>7/16 (11.3/19.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="564" pm="."><plain>55/67 (88.7/80.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="565" pm="."><plain>44/47 (71.0/56.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="566" pm="."><plain>18/36 (29.0/43.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="567" pm="."><plain>30/45 (48.4/54.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="568" pm="."><plain>32/38 (51.6/45.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="569" pm="."><plain>29/40 (46.8/48.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="570" pm="."><plain>33/43 (53.2/51.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="571" pm="."><plain>31/42 (50.0/50.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="572" pm="."><plain>31/41 (50.0/49.4) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="573" pm="."><plain>OR (95% CI) (c) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="574" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="575" pm="."><plain>1.86 (0.71–4.88) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="576" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="577" pm="."><plain>0.54 (0.26–1.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="578" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="579" pm="."><plain>1.31 (0.67–2.57) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="580" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="581" pm="."><plain>1.01 (0.51–1.99) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="582" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="583" pm="."><plain>1.11 (0.57–2.18) </plain></SENT>
</text></td></tr><tr><td colspan="11" align="left" rowspan="1"><text><SENT sid="584" pm="."><plain>Histological classification (*) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="585" pm="."><plain>PD/WD+MD </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="586" pm="."><plain>11/11 (13.9/19.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="587" pm="."><plain>68/46 (86.1/80.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="588" pm="."><plain>42/44 (53.2/77.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="589" pm="."><plain>37/13 (46.8/22.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="590" pm="."><plain>43/29 (54.4/50.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="591" pm="."><plain>36/28 (45.6/49.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="592" pm="."><plain>39/25 (49.4/43.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="593" pm="."><plain>40/32 (50.6/56.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="594" pm="."><plain>39/30 (49.4/52.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="595" pm="."><plain>40/27 (50.6/47.4) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="596" pm="."><plain>OR (95% CI) (c) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="597" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="598" pm="."><plain>1.60 (0.63–4.10) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="599" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="600" pm="."><plain>3.8 (1.69–8.56) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="601" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="602" pm="."><plain>1.31 (0.67–2.57) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="603" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="604" pm="."><plain>0.85 (0.42–1.74) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="605" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="606" pm="."><plain>1.21 (0.59–2.46) </plain></SENT>
</text></td></tr><tr><td colspan="11" align="left" rowspan="1"><text><SENT sid="607" pm="."><plain>Depth of invasion (#) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="608" pm="."><plain>T3+T4/T1+T2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="609" pm="."><plain>10/13 (18.5/14.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="610" pm="."><plain>44/78 (81.5/85.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="611" pm="."><plain>35/56 (64.8/61.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="612" pm="."><plain>19/35 (35.2/38.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="613" pm="."><plain>26/49 (48.1/53.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="614" pm="."><plain>28/42 (51.9/56.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="615" pm="."><plain>29/40 (53.7/44.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="616" pm="."><plain>25/51 (46.3/56.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="617" pm="."><plain>26/47 (48.1/51.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="618" pm="."><plain>28/44 (51.9/48.4) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="619" pm="."><plain>OR (95% CI) (c) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="620" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="621" pm="."><plain>0.75(0.30–1.86) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="622" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="623" pm="."><plain>0.99 (0.48–2.05) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="624" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="625" pm="."><plain>1.37 (0.68–2.76) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="626" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="627" pm="."><plain>0.73 (0.36–1.46) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="628" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="629" pm="."><plain>1.18 (0.5842.37) </plain></SENT>
</text></td></tr><tr><td colspan="11" align="left" rowspan="1"><text><SENT sid="630" pm="."><plain>Regional Lymph Node Metastasis </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="631" pm="."><plain>N+ve/N-ve </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="632" pm="."><plain>18/5 (15.1/19.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="633" pm="."><plain>101/21 (84.9/80.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="634" pm="."><plain>76/15 (63.9/57.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="635" pm="."><plain>43/11 (36.1/42.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="636" pm="."><plain>56/19 (47.1/73.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="637" pm="."><plain>63/7 (52.9/26.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="638" pm="."><plain>62/7 (52.1/26.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="639" pm="."><plain>57/19 (47.9/73.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="640" pm="."><plain>59/14 (49.6/53.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="641" pm="."><plain>60/12 (50.4/46.2) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="642" pm="."><plain>OR (95% CI) (c) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="643" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="644" pm="."><plain>1.32 (0.44–3.98) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="645" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="646" pm="."><plain>0.75 (0.31–1.81) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="647" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="648" pm="."><plain>3.04 (1.19–7.81) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="649" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="650" pm="."><plain>0.34 (0.13–0.88) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="651" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="652" pm="."><plain>1.14 (0.48–2.68) </plain></SENT>
</text></td></tr><tr><td colspan="11" align="left" rowspan="1"><text><SENT sid="653" pm="."><plain>Distant Metastasis </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="654" pm="."><plain>Yes/No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="655" pm="."><plain>6/17 (12.8/17.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="656" pm="."><plain>41/81 (87.2/82.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="657" pm="."><plain>31/60 (66.0/61.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="658" pm="."><plain>16/38 (34.0/38.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="659" pm="."><plain>27/48 (57.4/49.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="660" pm="."><plain>20/50 (42.6/51.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="661" pm="."><plain>28/41 (59.6/41.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="662" pm="."><plain>19/57 (40.4/58.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="663" pm="."><plain>23/50 (48.9/51.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="664" pm="."><plain>24/48 (51.1/49.0) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="665" pm="."><plain>OR (95% CI) (c) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="666" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="667" pm="."><plain>1.54 (0.55–4.33) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="668" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="669" pm="."><plain>0.87 (0.41–1.85) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="670" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="671" pm="."><plain>0.71 (0.35–1.46) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="672" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="673" pm="."><plain>0.49 (0.24–1.03) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="674" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="675" pm="."><plain>1.12 (0.55–2.29) </plain></SENT>
</text></td></tr><tr><td colspan="11" align="left" rowspan="1"><text><SENT sid="676" pm="."><plain>TNM classification(¥) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="677" pm="."><plain>Stage III+IV/I+II </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="678" pm="."><plain>13/10 (14.8/17.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="679" pm="."><plain>75/47 (85.2/82.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="680" pm="."><plain>59/32 (67.0/56.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="681" pm="."><plain>29/25 (33.0/43.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="682" pm="."><plain>43/32 (48.8/56.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="683" pm="."><plain>45/25 (51.2/43.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="684" pm="."><plain>46/23 (52.3/40.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="685" pm="."><plain>42/34 (47.7/59.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="686" pm="."><plain>42/31 (47.7/54.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="687" pm="."><plain>46/26 (52.3/45.6) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="688" pm="."><plain>OR (95% CI) (c) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="689" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="690" pm="."><plain>1.30 (0.52–3.25) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="691" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="692" pm="."><plain>0.66 (0.33–1.32) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="693" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="694" pm="."><plain>1.36 (0.69–2.68) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="695" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="696" pm="."><plain>0.63 (0.32–1.25) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="697" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="698" pm="."><plain>1.37 (0.69–2.72) </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt102"><label/><p><text><SENT sid="699" pm="."><plain>P value, ORs and 95% CIs were calculated by unconditional binary logistic regression (using SPSS v16 software) with respective reference genotypes. </plain></SENT>
<SENT sid="700" pm="."><plain>(a) Adjusted with Sex. </plain></SENT>
<SENT sid="701" pm="."><plain>(b) Adjusted with Age. </plain></SENT>
<SENT sid="702" pm="."><plain>(c) Adjusted with Age, Sex, and Addiction. </plain></SENT>
<SENT sid="703" pm="."><plain>Values in bold indicate positive significance (P&lt;0.05). </plain></SENT>
<SENT sid="704" pm="."><plain>(*) Histological classification is dependent on the basis of glandular architecture of adenocarcinoma. </plain></SENT>
<SENT sid="705" pm="."><plain>WD = Well differentiated, MD = Moderately differentiated, PD = poorly differentiated. </plain></SENT>
<SENT sid="706" pm="."><plain>(¥) Tumor stage is classified according to the criterion of the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC) TNM stage grouping [25]. </plain></SENT>
<SENT sid="707" pm="."><plain>(#) Depth of tumor defined according to the criterion of AJCC. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="708" pm="."><plain>MMP-1.1 and MMP-1.2 polymorphisms did not confer any significant risk for tumor location or degree of tumor progression in gastric cancer (Table 3). </plain></SENT>
<SENT sid="709" pm="."><plain>However patients carrying combination of AG and GG genotype of MMP-1.2 polymorphism were significantly distributed among histological subtypes of cancer and showed significantly greater risk for poorly differentiated (PD) carcinomas (p = 0.001, OR = 3.803, CI = 1.69–8.56) (Table 3). </plain></SENT>
</text></p><p><text><SENT sid="710" pm="."><plain>For MMP-1.3 polymorphism, patients carrying combination of TA and TT genotypes were at more risk of lower stomach cancer (lower &amp; middle body, antrum and pylorus of stomach) (p = 0.043, OR = 2.18, CI = 1.03–4.64). </plain></SENT>
<SENT sid="711" pm="."><plain>Also, the combination of TA and TT genotypes were found more frequently in gastric cancer patients with 10 or more metastatic lymph nodes (p = 0.021, OR = 3.044, CI = 1.187–7.807), suggesting that the T allele had a detrimental effects on gastric cancer progression and early metastasis (Table 3). </plain></SENT>
</text></p><p><text><SENT sid="712" pm="."><plain>For MMP-1.4 polymorphism, the distribution of TC and CC genotypes among patients with different tumor locations in the stomach was close to reaching a statistical significant association with the risk of lower stomach cancer (p = 0.075, OR = 1.969, CI = 0.94–4.15) (Table 3). </plain></SENT>
<SENT sid="713" pm="."><plain>Contradictory to MMP-1.3 polymorphism, patients carrying a combination of TC and CC genotypes gave protection against regional lymph node metastasis (p = 0.026, OR = 0.34, CI = 0.13–0.88) in addition to distant metastasis (p = 0.061, OR = 0.49, CI = 0.24–1.03) of gastric cancer (Table 3). </plain></SENT>
</text></p><p><text><SENT sid="714" pm="."><plain>For MMP-1.5 polymorphism, a combination of TC and CC genotypes showed a significant association with location of stomach tumor. </plain></SENT>
<SENT sid="715" pm="."><plain>Patients carrying a combination of TC and CC genotypes were at more risk of lower stomach cancer (p = 0.034, OR = 2.22, CI = 1.06–4.07) (Table 3). </plain></SENT>
</text></p><p><text><SENT sid="716" pm="."><plain>In stratification analysis for SNPs and lower stomach tumor formation, the study would have reached a power of 80% (Z-alpha = 1.645, for alpha = 0.05) with 89 lower stomach cases, lower stomach and upper stomach sample ratio of 0.505 and 35% exposed upper stomach patients to the risk allele having OR of 2.5. </plain></SENT>
</text></p></sec><sec id="s3e"><title><text><SENT sid="717" pm="."><plain>Genotype Frequency at Two Linked Loci of MMP-1 SNPs and Risk to Gastric Cancer </plain></SENT>
</text></title><p><text><SENT sid="718" pm="."><plain>To evaluate the combined effects of two linked loci on the risk of cancer, as individual SNPs did not confer risk for gastric cancer development, the combined genotype frequencies were compared in patients and controls. </plain></SENT>
<SENT sid="719" pm="."><plain>Distributions of paired loci frequencies for adjacent polymorphisms were observed with increasing order of variant allele and associations were examined. </plain></SENT>
<SENT sid="720" pm="."><plain>There was no dose dependent association observed, the number of variant allele was increased for any combination of adjacent paired loci (Table 4). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0088040-t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0088040.t004</object-id><label>Table 4</label><caption><title><text><SENT sid="721" pm="."><plain>Distribution of MMP-1 paired loci polymorphisms with increasing order of variant alleles and association with the gastric cancer risk. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0088040-t004-4" xlink:href="pone.0088040.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="722" pm="."><plain>MMP-1.1-1.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="723" pm="."><plain>Con </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="724" pm="."><plain>Patient </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="725" pm="."><plain>OR </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="726" pm="."><plain>95% CI </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="727" pm="."><plain>P </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="728" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="729" pm="."><plain>13 (9.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="730" pm="."><plain>16 (11.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="731" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="732" pm="."><plain>1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="733" pm="."><plain>49 (33.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="734" pm="."><plain>37 (25.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="735" pm="."><plain>0.529 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="736" pm="."><plain>0.201–1.390 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="737" pm="."><plain>0.286 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="738" pm="."><plain>2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="739" pm="."><plain>71 (49.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="740" pm="."><plain>76 (52.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="741" pm="."><plain>0.576 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="742" pm="."><plain>0.231–1.431 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="743" pm="."><plain>0.329 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="744" pm="."><plain>3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="745" pm="."><plain>12 (8.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="746" pm="."><plain>16 (11.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="747" pm="."><plain>0.727 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="748" pm="."><plain>0.231–2.285 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="749" pm="."><plain>0.798 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="750" pm="."><plain>4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="751" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="752" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="753" pm="."><plain>* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="754" pm="."><plain>MMP-1.2-1.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="755" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="756" pm="."><plain>49 (33.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="757" pm="."><plain>45 (31.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="758" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="759" pm="."><plain>1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="760" pm="."><plain>67 (46.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="761" pm="."><plain>64 (44.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="762" pm="."><plain>0.948 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="763" pm="."><plain>0.537–1.674 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="764" pm="."><plain>0.885 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="765" pm="."><plain>2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="766" pm="."><plain>20 (13.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="767" pm="."><plain>26 (17.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="768" pm="."><plain>1.04 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="769" pm="."><plain>0.501–2.157 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="770" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="771" pm="."><plain>3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="772" pm="."><plain>9 (6.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="773" pm="."><plain>10 (6.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="774" pm="."><plain>0.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="775" pm="."><plain>0.300–2.131 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="776" pm="."><plain>0.803 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="777" pm="."><plain>4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="778" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="779" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="780" pm="."><plain>* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="781" pm="."><plain>MMP-1.3-1.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="782" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="783" pm="."><plain>45 (31.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="784" pm="."><plain>39 (26.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="785" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="786" pm="."><plain>1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="787" pm="."><plain>54 (37.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="788" pm="."><plain>57 (39.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="789" pm="."><plain>0.984 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="790" pm="."><plain>0.535–1.815 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="791" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="792" pm="."><plain>2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="793" pm="."><plain>30 (20.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="794" pm="."><plain>31 (21.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="795" pm="."><plain>0.985 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="796" pm="."><plain>0.486–1.999 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="797" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="798" pm="."><plain>3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="799" pm="."><plain>16 (11.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="800" pm="."><plain>16 (11.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="801" pm="."><plain>0.848 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="802" pm="."><plain>0.363–1.98 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="803" pm="."><plain>0.829 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="804" pm="."><plain>4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="805" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="806" pm="."><plain>2 (1.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="807" pm="."><plain>0.53 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="808" pm="."><plain>0.083–3.373 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="809" pm="."><plain>0.653 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="810" pm="."><plain>MMP-1.4-1.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="811" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="812" pm="."><plain>27 (18.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="813" pm="."><plain>25 (17.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="814" pm="."><plain>1 (Ref) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="815" pm="."><plain>1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="816" pm="."><plain>67 (46.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="817" pm="."><plain>69 (47.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="818" pm="."><plain>0.936 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="819" pm="."><plain>0.468–1.873 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="820" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="821" pm="."><plain>2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="822" pm="."><plain>51 (35.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="823" pm="."><plain>51 (35.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="824" pm="."><plain>0.861 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="825" pm="."><plain>0.419–1.768 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="826" pm="."><plain>0.718 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="827" pm="."><plain>3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="828" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="829" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="830" pm="."><plain>* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="831" pm="."><plain>4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="832" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="833" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="834" pm="."><plain>* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label/><p><text><SENT sid="835" pm="."><plain>OR, odds ratio; CI, confidence interval; Ref, reference. </plain></SENT>
</text></p></fn><fn id="nt104"><label/><p><text><SENT sid="836" pm="."><plain>0 = no risk allele for both loci, 1 = one risk allele for any one loci, 2 = two risk allele for both the loci, 3 = one risk allele for any one locus and two risk allele for another locus, 4 = All risk allele for both the loci. </plain></SENT>
</text></p></fn><fn id="nt105"><label/><p><text><SENT sid="837" pm="."><plain>Adjusted OR calculated for age, sex, addiction, by binary logistic regression model using SPSS v16.0 software. </plain></SENT>
</text></p></fn><fn id="nt106"><label/><p><text><SENT sid="838" pm="."><plain>P value is for χ2-test showing the significance of difference in the distributions of the variant alleles between patients and controls. </plain></SENT>
</text></p></fn><fn id="nt107"><label/><p><text><SENT sid="839" pm="."><plain>Values in bold indicate positive significance (P&lt;0.05). </plain></SENT>
</text></p></fn><fn id="nt108"><label/><p><text><SENT sid="840" pm="."><plain>No risk allele for both the gene was taken as reference to calculate OR. </plain></SENT>
</text></p></fn><fn id="nt109"><label/><p><text><SENT sid="841" pm="."><plain>(*) OR not calculated because of very low frequency in both control and patient population. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="s3f"><title><text><SENT sid="842" pm="."><plain>Linkage Disequilibrium between the SNPs of MMP-1 Promoter and Haplotype Frequencies with the Susceptibility to Gastric Cancer </plain></SENT>
</text></title><p><text><SENT sid="843" pm="."><plain>All the polymorphisms in the MMP-1 gene promoter were assessed for linkage disequilibrium (LD) between the polymorphisms and to identify common haplotypes present in the patient and control cohorts. </plain></SENT>
<SENT sid="844" pm="."><plain>The region showed low to substantial LD between the polymorphisms, except MMP-1.4 and MMP-1.5 which were in complete LD in the case-control study cohort (Figure 1) (The linkage disequilibrium block definitions were based on the method of Gabriel et al.) [32]. </plain></SENT>
<SENT sid="845" pm="."><plain>Sixteen haplotypes were identified with a frequency higher than 1% both in control and patient population, including all the five markers covering the MMP-1 gene promoter. </plain></SENT>
<SENT sid="846" pm="."><plain>The extended haplotype frequency distributions of MMP-1 polymorphisms were not significant between gastric cancer patients and controls and none of these haplotypes conferred risk for gastric cancer occurrence (data not shown). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0088040-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0088040.g001</object-id><label>Figure 1</label><caption><title><text><SENT sid="847" pm="."><plain>Gene map and LD structure of MMP-1 promoter locus. </plain></SENT>
</text></title><p><text><SENT sid="848" pm="."><plain>(A) SNP positions in the gene map of MMP-1 gene (prepared using NCBI sequence viewer) in human chromosome 11. </plain></SENT>
<SENT sid="849" pm="."><plain>Different color schemes are assigned to show each SNP position in the map by marking the map according to the reference assembly (HuRef NCBI Build 36.7) position of the SNP in the chromosome. </plain></SENT>
<SENT sid="850" pm="."><plain>The number in different colored boxes indicates the SNP alias number used in our study. </plain></SENT>
<SENT sid="851" pm="."><plain>(B) LD structure of MMP-1 promoter locus SNPs. </plain></SENT>
<SENT sid="852" pm="."><plain>Linkage disequilibrium plots follows the GOLD heat map Haploview 4.2 color scheme. </plain></SENT>
<SENT sid="853" pm="."><plain>Block definition is based on the method of Gabriel et al. [32]. </plain></SENT>
<SENT sid="854" pm="."><plain>Haploview plot of MMP-1 SNPs genotyped in 290 subjects (145 patients and 145 controls common for all SNPs studied) in our study. </plain></SENT>
<SENT sid="855" pm="."><plain>Numbers in squares are pair wise D' values between SNPs. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0088040.g001"/></fig></SecTag></sec><sec id="s3g"><title><text><SENT sid="856" pm="."><plain>Functional Haplotype Effects of MMP-1 Polymorphisms’ on Lower Stomach Tumor Formation </plain></SENT>
</text></title><p><text><SENT sid="857" pm="."><plain>Sixteen haplotypes were identified with a frequency higher than 1% and categorized by increasing order of polymorphic variant alleles and analyzed for gene-dosage effect (Table S1 in File S1). </plain></SENT>
<SENT sid="858" pm="."><plain>The difference in the haplotype frequency was significant between lower stomach gastric cancer patients and upper stomach gastric cancer patients as the number of polymorphic variant alleles were increased resulting in the increase of risk for lower stomach gastric cancer development with highest OR of 2.155, 95% CI = 1.317–3.526, P = 0.0028, χ2 = 9.52 for combined haplotypes containing 4 risk alleles (Table 5). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0088040-t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0088040.t005</object-id><label>Table 5</label><caption><title><text><SENT sid="859" pm="."><plain>Association of increasing order of MMP-1 polymorphic variant alleles in haplotypes with Lower stomach gastric cancer risk. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0088040-t005-5" xlink:href="pone.0088040.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="860" pm="."><plain>Haplotype </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="861" pm="."><plain>Upper Stomach </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="862" pm="."><plain>Lower Stomach </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="863" pm="."><plain>OR </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="864" pm="."><plain>95% CI </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="865" pm="."><plain>P </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="866" pm="."><plain>χ2 (Pearson) </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="867" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="868" pm="."><plain>0.138 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="869" pm="."><plain>0.091 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="870" pm="."><plain>Ref </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="871" pm="."><plain>1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="872" pm="."><plain>0.336 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="873" pm="."><plain>0.379 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="874" pm="."><plain>1.711 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="875" pm="."><plain>1.264–2.315 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="876" pm="."><plain>0.0005 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="877" pm="."><plain>12.22 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="878" pm="."><plain>2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="879" pm="."><plain>0.328 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="880" pm="."><plain>0.298 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="881" pm="."><plain>1.378 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="882" pm="."><plain>1.013–1.874 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="883" pm="."><plain>0.0439 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="884" pm="."><plain>4.18 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="885" pm="."><plain>3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="886" pm="."><plain>0.159 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="887" pm="."><plain>0.177 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="888" pm="."><plain>1.688 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="889" pm="."><plain>1.201–2.373 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="890" pm="."><plain>0.0027 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="891" pm="."><plain>9.15 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="892" pm="."><plain>4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="893" pm="."><plain>0.038 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="894" pm="."><plain>0.054 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="895" pm="."><plain>2.155 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="896" pm="."><plain>1.317–3.526 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="897" pm="."><plain>0.0028 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="898" pm="."><plain>9.52 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="899" pm="."><plain>5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="900" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="901" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt110"><label/><p><text><SENT sid="902" pm="."><plain>Haplotypes order as MMP-1.1-MMP-1.2-MMP-1.3-MMP-1.4-MMP-1.5. </plain></SENT>
</text></p></fn><fn id="nt111"><label/><p><text><SENT sid="903" pm="."><plain>(a) two sided χ2 Association P value, OR = Odds ratio, CI = Confidence Interval, Ref = Reference haplotype to calculate OR. </plain></SENT>
<SENT sid="904" pm="."><plain>Other possible combinations of linked loci are omitted because of null frequency in the population. </plain></SENT>
<SENT sid="905" pm="."><plain>Haplotype frequency and haplotype association test performed using Haploview4.2 software. </plain></SENT>
<SENT sid="906" pm="."><plain>Haplotype numbers denote the number of risk allele(s) present in the haplotypes. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="907" pm="."><plain>In order to investigate the impact of MMP-1 promoter polymorphisms on the gene function, we compared serum MMP-1 level by serum ELISA in patients having lower stomach cancer with combined risk haplotypes (having at least any one risk allele) vs. upper stomach cancer with the reference haplotype (1G-A-A-T-T). </plain></SENT>
<SENT sid="908" pm="."><plain>The serum MMP-1 protein concentration was almost 1.5 fold higher in patients with lower stomach cancer (n = 54) (with combined risk haplotypes) than patients with upper stomach cancer (n = 15) (with reference haplotype; p = 0.024), suggesting the functional importance of these SNPs in the regulation of MMP-1 gene expression and there by influencing the lower stomach carcinogenesis process (Figure 2). </plain></SENT>
<SENT sid="909" pm="."><plain>The analysis has been repeated and confirmed upon log transforming the data (Figure S2 in File S1). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0088040-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0088040.g002</object-id><label>Figure 2</label><caption><title><text><SENT sid="910" pm="."><plain>Haplotype effect on serum MMP-1 concentration. </plain></SENT>
</text></title><p><text><SENT sid="911" pm="."><plain>Serum MMP-1 level in patients with lower stomach cancer with risk haplotypes (n = 54), and upper stomach cancer with non risk haplotypes (n = 15) were compared by ELISA. </plain></SENT>
<SENT sid="912" pm="."><plain>Results showed patients with lower stomach cancer exhibit a 1.43 fold higher MMP-1 level than in upper stomach cancer patients (p&lt;0.05 by t-test) (box whisker diagram). </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0088040.g002"/></fig></SecTag></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="s4"><title><text><SENT sid="913" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="914" pm="."><plain>Although MMPs are not oncogenic or mutagenic, they alter the microenvironment and may affect the process of carcinogenesis and its histology, and appear to be induced at the level of transcriptional activation [33]. </plain></SENT>
<SENT sid="915" pm="."><plain>Being a member of MMP family, MMP-1 has been reported to play an important role in cancer invasion through overexpression, which is associated with metastasis and poor prognosis in esophageal cancer, ovarian cancer, cutaneous malignant melanoma, colorectal cancer and gastric cancer [11], [15], [16], [25], [34]. </plain></SENT>
<SENT sid="916" pm="."><plain>Diffuse types of gastric cancer are usually characterized by an abundant deposition of collagen fibers, possibly requiring higher levels of MMP-1 expression for proper tissue remodeling of the microenvironment [30]. </plain></SENT>
<SENT sid="917" pm="."><plain>The genetic background has been suggested to play an important role in the incidence and progression of gastric cancer [30]. </plain></SENT>
<SENT sid="918" pm="."><plain>In addition, some polymorphic genes encoding metabolic enzymes and cell cycle regulators, such as methylene tetrahydrofolate reductase, NADPH: quinone oxidoreductase and Cyclin D1 have been documented to confer a susceptibility to gastric cancer [35]–[37]. </plain></SENT>
<SENT sid="919" pm="."><plain>Therefore, polymorphic genes, alone, in combination with others or through interaction with exogenous risk factors, may be used as predicative parameters for screening individuals at a high risk of gastric cancer. </plain></SENT>
</text></p><p><text><SENT sid="920" pm="."><plain>To the best of our knowledge, this study of the association of MMP-1 variants and the risk of gastric cancer development and progression in an eastern Indian population is the first of its kind with a focus on a −1607 1G/2G polymorphism (MMP-1.1), and an additional four polymorphisms between this SNP and the transcription start site. </plain></SENT>
<SENT sid="921" pm="."><plain>MMP-1 promoter region functional polymorphisms responsible for its expressional alterations have been correlated with various disease processes. </plain></SENT>
<SENT sid="922" pm="."><plain>Despite this, in our study MMP-1.1 polymorphism and additionally four other SNPs (MMP-1.1, MMP-1.2, MMP-1.3 and MMP-1.4) in the promoter region are not correlated with gastric cancer occurrence, suggesting these promoter variants to be low penetrance risk factors in gastric cancer. </plain></SENT>
<SENT sid="923" pm="."><plain>The mitogen-activated protein kinase signaling pathway regulates MMP-1 gene expression by activating cofactors that interact with AP1 and polyoma-enhancing activity–3/E26 virus (PEA3/Ets) transcription factor-binding sites located within the promoter region [38]. </plain></SENT>
<SENT sid="924" pm="."><plain>It is well known that the 2G type of SNP at −1607 (MMP-1.1) in the promoter of MMP-1 creates a core recognition sequence (5′-GGAT-3′) that represents the binding site for Ets family transcription factors. </plain></SENT>
<SENT sid="925" pm="."><plain>The promoter containing the 2G allele displays significantly higher transcriptional activity than the 1G allele in normal fibroblasts and melanoma cells [13]. </plain></SENT>
<SENT sid="926" pm="."><plain>Also, Ets transcription factors can positively and negatively activate transcription by interaction with coregulatory-binding partners or by regulating phosphorylation [38]. </plain></SENT>
<SENT sid="927" pm="."><plain>This suggests that the Ets family proteins and partner proteins may differ in various cell types [38]. </plain></SENT>
<SENT sid="928" pm="."><plain>Alternatively, other pathways regulating MMP-1 expression may act independently of the SNP at −1607 bp [39]. </plain></SENT>
<SENT sid="929" pm="."><plain>Similar results for MMP-1.1 polymorphism have been reported in other investigations on gastric cancer using Japanese populations, gastric cardiac adenocarcinoma (GCA) in a Chinese population, and prostate cancer in a Turkish population. </plain></SENT>
<SENT sid="930" pm="."><plain>However contradictory results have been reported in other investigations on colorectal cancer using Japanese, Korean and Italian populations [15]–[17], [30], [31], [40]. </plain></SENT>
<SENT sid="931" pm="."><plain>The 2G allele appears to be more frequently identified in Asian populations than in European populations [16], [30], [41], and this is also supported by our data. </plain></SENT>
<SENT sid="932" pm="."><plain>These discordant results may be a consequence of the number of subjects, the ethnicity of the population and the source of DNA (tumor derived compared to normal genomic) [20]. </plain></SENT>
</text></p><p><text><SENT sid="933" pm="."><plain>Patients having combination of the TA and TT genotype for MMP-1.3 polymorphism, a combination of the TC and CC genotype for MMP-1.4 polymorphism, and a combination of the TC and CC genotype for MMP-1.5 polymorphism are at more risk of lower stomach cancer (lower &amp; middle body, antrum and pylorus of stomach), suggesting that these three polymorphisms, separately or in combination may be used as a marker for diagnosing and treating patients having lower stomach cancer in our population. </plain></SENT>
<SENT sid="934" pm="."><plain>In India, a trend towards an increase in the incidence of cardia tumors (upper stomach cancer) was observed from different cancer registries. </plain></SENT>
<SENT sid="935" pm="."><plain>Contradictory results were found for our population showing higher incidence of noncardia cancers (lower stomach cancer) (64%) suggesting Indian cancer registries may have inadequate data regarding eastern Indian populations, especially for the region of West Bengal, Bihar and Orissa. </plain></SENT>
<SENT sid="936" pm="."><plain>Further, these observed differences between gastric cancers by anatomic site and risk of lower stomach cancer incidence with respect to three adjacent SNPs near the transcription start site of the MMP-1 gene suggest that they are distinct diseases with different epidemiological etiologies which may be governed by these polymorphisms in the eastern Indian region. </plain></SENT>
<SENT sid="937" pm="."><plain>Detailed epidemiological analyses of their demographic trends and risk factors in other cancer types in similar populations will help us to apply new strategies to control cancer. </plain></SENT>
<SENT sid="938" pm="."><plain>Also, no previous information is available for these polymorphisms in the occurrence of gastric cancer. </plain></SENT>
<SENT sid="939" pm="."><plain>So, further studies need to confirm our findings in larger sample sizes and in other populations. </plain></SENT>
</text></p><p><text><SENT sid="940" pm="."><plain>In chondrosarcoma, esophageal cancer and melanoma, patients with increased levels of MMP-1 expression are correlated with a worse outcome regarding tumor invasion and metastasis [38]. </plain></SENT>
<SENT sid="941" pm="."><plain>Additionally, the MMP-1.1 2G allele may be implicated in the differentiation of gastric cancer, lymph node metastasis of breast cancer, in decreasing the age of onset in male smokers of lung cancer and tumors with infiltrative growth, and in lymph node metastases in colorectal cancer [21], [30], [42], [43]. </plain></SENT>
<SENT sid="942" pm="."><plain>However, stratification analyses with respect to gastric cancer progression in our study shows, those MMP-1 promoter polymorphisms are not significantly associated with invasion, lymph node metastasis, distant metastasis and thus TNM classification of gastric cancer, with some exceptional contradictions. </plain></SENT>
<SENT sid="943" pm="."><plain>MMP-1.3 polymorphism which shows a positive significance (p = 0.021) for regional lymph node metastasis having a combination of TA and TT genotype, suggests that the T allele has a detrimental effect on gastric cancer progression and early metastasis. </plain></SENT>
<SENT sid="944" pm="."><plain>MMP-1.4 polymorphism with a combination of the TC and CC genotype shows a negative correlation for regional lymph node metastasis in addition to distant metastasis, contradicting MMP-1.3 polymorphism. </plain></SENT>
<SENT sid="945" pm="."><plain>Possible explanations for this observation may reside in the degree of tumor invasion, further, metastasis in gastric carcinoma might also determined by the response to growth factors and cytokines besides the presence of 2G, G, T, C, C alleles (respectively for MMP-1.1, -1.2, -1.3, -1.4 and -1.5) in the MMP-1 promoter. </plain></SENT>
<SENT sid="946" pm="."><plain>Cytokines, such as interleukin-1 (IL-1), influence the expression levels of MMP-1 and act as growth stimulators correlating with liver metastasis of gastric carcinoma [44]–[46]. </plain></SENT>
<SENT sid="947" pm="."><plain>The MMP-1.1 polymorphism may increase the MMP-1 expression in response to growth factors and cytokines [47]. </plain></SENT>
<SENT sid="948" pm="."><plain>Transcriptional regulation is a complex process that is often influenced by tissue-specific factors. </plain></SENT>
<SENT sid="949" pm="."><plain>Although various human tumor tissues have demonstrated co-expression of Ets factor and MMP-1, there was no correlation observed between Ets expression and metastasis in pancreatic and thyroid carcinoma [48], [49]. </plain></SENT>
<SENT sid="950" pm="."><plain>Therefore, it is possible that MMP-1 transcriptional regulation is not directly increased by the presence of this Ets-binding site [38]. </plain></SENT>
<SENT sid="951" pm="."><plain>This suggests that gene expression secondary to MMP-1 SNPs is tissue specific and varies functionally between different disease processes [38]. </plain></SENT>
<SENT sid="952" pm="."><plain>So, the presence of polymorphic alleles of the MMP-1 promoter may not necessarily contribute to the degree of tumor invasion and in addition to progression of gastric carcinoma. </plain></SENT>
<SENT sid="953" pm="."><plain>However, we found a significant association between the MMP-1.2 polymorphism and the histological classification. </plain></SENT>
<SENT sid="954" pm="."><plain>Patients carrying at least one G allele have showed significantly greater risk for poorly differentiated (PD) carcinomas (p = 0.001). </plain></SENT>
<SENT sid="955" pm="."><plain>This finding is not observed for other SNPs in the promoter region. </plain></SENT>
<SENT sid="956" pm="."><plain>The histological determination of tumor grade and the subsequent clinical course of gastric cancer is subjective in nature, and more objective methods have been unsuccessfully sought to assess prognosis [38]. </plain></SENT>
</text></p><p><text><SENT sid="957" pm="."><plain>An increasing number of studies have shown that a disease phenotype can be associated with a linked loci or haplotype made up of polymorphisms that are not individually associated with the phenotype [50]. </plain></SENT>
<SENT sid="958" pm="."><plain>Functional studies showed that the MMP-1 promoter polymorphisms exert haplotype effects on MMP-1 promoter activity in cancer cells [50]. </plain></SENT>
<SENT sid="959" pm="."><plain>In our population, combinations of paired loci of adjacent polymorphisms do not exert any significant increased or decreased risk for gastric cancer and a gene-dose effect study confirmed the finding. </plain></SENT>
<SENT sid="960" pm="."><plain>Our study showed that the degree of linkage disequilibrium between the polymorphisms in the MMP-1 gene promoter is substantially low. </plain></SENT>
<SENT sid="961" pm="."><plain>The low degree of linkage disequilibrium between the MMP-1 gene polymorphisms likely reflects the presence of recombination hotspots at this genomic locus. </plain></SENT>
<SENT sid="962" pm="."><plain>Three of the five polymorphisms, i.e., MMP-1.2 (rs1144393), MMP-1.3 (rs475007) and MMP-1.4 (rs514921) have been studied in the international HapMap project, and have been shown to be located near a recombination hotspot and thus accounted for low LD [24]. </plain></SENT>
<SENT sid="963" pm="."><plain>We found nearly 16 haplotypes for studied MMP-1 polymorphisms, none of which contribute a major part in the population. </plain></SENT>
<SENT sid="964" pm="."><plain>In the MMP-1 gene promoter, in which linkage disequilibrium between polymorphisms is substantially weaker, to partition the different haplotypes would require the genotyping of four of the five polymorphisms (MMP-1.1 and MMP-1.5 are in complete linkage). </plain></SENT>
<SENT sid="965" pm="."><plain>Also the distribution of haplotypes of all five SNPs between patients and controls was not found to be differentially distributed, and this may be due to the possibility that individual SNPs do not exert risk for the disease. </plain></SENT>
<SENT sid="966" pm="."><plain>However, we have found a functional correlation of MMP-1 promoter polymorphic haplotypes with MMP-1 expression in a locoregional manner of gastric cancer occurrence. </plain></SENT>
<SENT sid="967" pm="."><plain>Thus it can be hypothesized that, MMP-1 promoter haplotypes may have functional importance in regulation of MMP-1 gene transcription, resulted in altered expression. </plain></SENT>
<SENT sid="968" pm="."><plain>This suggests MMP-1 functional polymorphic haplotypes may be a prognostic factor for locoregional gastric cancer progression. </plain></SENT>
</text></p><p><text><SENT sid="969" pm="."><plain>To date, most genetic epidemiology studies of MMP-1 gene variation in relation to cancers have focused on the −1607 1G/2G polymorphism [15]–[17], [30], [31], [40], [41]. </plain></SENT>
<SENT sid="970" pm="."><plain>The results of our study indicate a need for genotyping additional polymorphisms in the MMP-1 gene promoter and undertaking haplotype analysis, as typing the −1607 1G/2G polymorphism alone cannot fully segregate the various MMP-1 haplotypes that may differ in promoter activity. </plain></SENT>
<SENT sid="971" pm="."><plain>Further studies will be required to determine the MMP-1 haplotypes and their frequencies in other populations. </plain></SENT>
</text></p><p><text><SENT sid="972" pm="."><plain>In conclusion, our study suggests that MMP-1.3, MMP-1.4 and MMP-1.5 polymorphisms in the MMP-1 promoter enhances the risk of lower stomach tumor formation in an eastern Indian population. </plain></SENT>
<SENT sid="973" pm="."><plain>In addition, our results suggest these three adjacent polymorphisms in the MMP-1 gene promoter to be functionally important in affecting MMP-1 gene transcription, subsequently reflected in serum MMP-1 levels. </plain></SENT>
<SENT sid="974" pm="."><plain>Furthermore, we found that MMP-1.3 polymorphism contributed to the susceptibility of lymph node metastasis. </plain></SENT>
<SENT sid="975" pm="."><plain>However the current study reveals that all these three SNPs are not independent prognostic parameters to predict the outcome of patients with gastric cancer. </plain></SENT>
<SENT sid="976" pm="."><plain>Due to the small sample size we are unable to find any association of these polymorphisms with gastric cancer risk. </plain></SENT>
<SENT sid="977" pm="."><plain>Detailed epidemiological analyses of these SNPs, demographic trends and risk factors in other diseases in similar populations in addition to larger sample sizes are welcome in order to strengthen our findings. </plain></SENT>
<SENT sid="978" pm="."><plain>Further research may be helpful to determine whether our observations are tumor specific or applicable to other adenocarcinomas such as breast, prostate or lung cancer. </plain></SENT>
<SENT sid="979" pm="."><plain>Our data might serve a useful predictive parameter for early identification of individuals at-risk of lower stomach cancer and could aid strategies to optimize treatment for a disease such as gastric cancer. </plain></SENT>
</text></p></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="s5"><title><text><SENT sid="980" pm="."><plain>Supporting Information </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="pone.0088040.s001"><label>File S1</label><caption><p><text><SENT sid="981" pm="."><plain>Contains the following files: Table S1: Overall Haplotype distribution of MMP1 SNPs in lower stomach and upper stomach gastric cancer patients and association with gastric cancer risk. Figure S1: Genotyping of the MMP1 polymorphisms. Figure S2: Haplotype effect on serum MMP-1 concentration. </plain></SENT>
</text></p><p><text><SENT sid="982" pm="."><plain>(DOC) </plain></SENT>
</text></p></caption><media xlink:href="pone.0088040.s001.doc"><caption><p><text><SENT sid="983" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></sec></SecTag></body><back><SecTag type="AUTH_CONT"><ack><p>Department of Gastric Surgery, Medical College and Hospital, Kolkata, India and Institute of Post Graduate Medical Education and Research, Kolkata, India were kind enough to provide blood samples and patients’ documents, Prof. Siddhartha Roy, Director, IICB, Kolkata, India, constantly supported the work and authors are grateful to them for their contributions. The authors are thankful to Dr. Jeremy Ollerenshaw, Kimberly-Clark Health Care, Roswell, GA for editing the manuscript and Dr. Indranil Mukhopadhyay, Human Genetics Division, Indian Statistical Institute (ISI) Kolkata, India for the statistical evaluation of the manuscript.</p></ack></SecTag><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0088040-Ferlay1"><text><SENT sid="984" pm="."><plain>1 FerlayJ, ShinHR, BrayF, FormanD, MathersC, et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127: 2893–2917.21351269 </plain></SENT>
</text></ref><ref id="pone.0088040-Dikshit1"><text><SENT sid="985" pm="."><plain>2 DikshitRP, MathurG, MhatreS, YeoleBB (2011) Epidemiological review of gastric cancer in India. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical &amp; Paediatric Oncology 32: 3–11. </plain></SENT>
</text></ref><ref id="pone.0088040-Helicobacter1"><text><SENT sid="986" pm="."><plain>3 Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49: 347–353.11511555 </plain></SENT>
</text></ref><ref id="pone.0088040-Park1"><text><SENT sid="987" pm="."><plain>4 ParkCC, BissellMJ, Barcellos-HoffMH (2000) The influence of the microenvironment on the malignant phenotype. Molecular Medicine Today 6: 324–329.10904250 </plain></SENT>
</text></ref><ref id="pone.0088040-Lukashev1"><text><SENT sid="988" pm="."><plain>5 LukashevME, WerbZ (1998) ECM signalling: orchestrating cell behaviour and misbehaviour. Trends in Cell Biology 8: 437–441.9854310 </plain></SENT>
</text></ref><ref id="pone.0088040-Vincenti1"><text><SENT sid="989" pm="."><plain>6 VincentiMP, WhiteLA, SchroenDJ, BenbowU, BrinckerhoffCE (1996) Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): Mechanisms that control enzyme activity, transcription, and mRNA stability. Critical Reviews in Eukaryotic Gene Expression 6: 391–411.8959374 </plain></SENT>
</text></ref><ref id="pone.0088040-Pulukuri1"><text><SENT sid="990" pm="."><plain>7 PulukuriSM, RaoJS (2008) Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. International journal of oncology 32: 757–765.18360703 </plain></SENT>
</text></ref><ref id="pone.0088040-Chambers1"><text><SENT sid="991" pm="."><plain>8 ChambersAF, MatrisianLM (1997) Changing views of the role of matrix metalloproteinases in metastasis. Journal of the National Cancer Institute 89: 1260–1270.9293916 </plain></SENT>
</text></ref><ref id="pone.0088040-Hewitt1"><text><SENT sid="992" pm="."><plain>9 HewittRE, LeachIH, PoweDG, ClarkIM, CawstonTE, et al (1991) Distribution of Collagenase and Tissue Inhibitor of Metalloproteinases (Timp) in Colorectal Tumors. International Journal of Cancer 49: 666–672.1657796 </plain></SENT>
</text></ref><ref id="pone.0088040-Murray1"><text><SENT sid="993" pm="."><plain>10 MurrayGI, DuncanME, ArbuckleE, MelvinWT, FothergillJE (1998) Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 43: 791–797.9824606 </plain></SENT>
</text></ref><ref id="pone.0088040-Murray2"><text><SENT sid="994" pm="."><plain>11 MurrayGI, DuncanME, O'NeilP, McKayJA, MelvinWT, et al (1998) Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. Journal of Pathology 185: 256–261.9771478 </plain></SENT>
</text></ref><ref id="pone.0088040-Baker1"><text><SENT sid="995" pm="."><plain>12 BakerEA, LeaperDJ (2003) The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology. European Journal of Cancer 39: 981–988.12706368 </plain></SENT>
</text></ref><ref id="pone.0088040-Rutter1"><text><SENT sid="996" pm="."><plain>13 RutterJL, MitchellTI, ButticeG, MeyersJ, GusellaJF, et al (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Research 58: 5321–5325.9850057 </plain></SENT>
</text></ref><ref id="pone.0088040-Nishioka1"><text><SENT sid="997" pm="."><plain>14 NishiokaY, KobayashiK, SagaeS, IshiokaS, NishikawaA, et al (2000) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Japanese Journal of Cancer Research 91: 612–615.10874213 </plain></SENT>
</text></ref><ref id="pone.0088040-Kanamori1"><text><SENT sid="998" pm="."><plain>15 KanamoriY, MatsushimaM, MinaguchiT, KobayashiK, SagaeS, et al (1999) Correlation between expression of the Matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Research 59: 4225–4227.10485461 </plain></SENT>
</text></ref><ref id="pone.0088040-Ghilardi1"><text><SENT sid="999" pm="."><plain>16 GhilardiG, BiondiML, MangoniJ, LevitiS, DeMontiM, et al (2001) Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clinical Cancer Research 7: 2344–2346.11489811 </plain></SENT>
</text></ref><ref id="pone.0088040-Hinoda1"><text><SENT sid="1000" pm="."><plain>17 HinodaY, OkayamaN, TakanoN, FujimuraK, SuehiroY, et al (2002) Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. International Journal of Cancer 102: 526–529.12432557 </plain></SENT>
</text></ref><ref id="pone.0088040-Zinzindohoue1"><text><SENT sid="1001" pm="."><plain>18 ZinzindohoueF, LecomteT, FerrazJM, HoullierAM, CugnencPH, et al (2005) Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Clinical Cancer Research 11: 594–599.15701845 </plain></SENT>
</text></ref><ref id="pone.0088040-Elander1"><text><SENT sid="1002" pm="."><plain>19 ElanderN, SoderkvistP, FransenK (2006) Matrix metalloproteinase (MMP)-1,-2,-3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Research 26: 791–795.16739355 </plain></SENT>
</text></ref><ref id="pone.0088040-Hettiaratchi1"><text><SENT sid="1003" pm="."><plain>20 HettiaratchiA, HawkinsNJ, McKenzieG, WardRL, HuntJE, et al (2007) The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer. British Journal of Cancer 96: 783–792.17311017 </plain></SENT>
</text></ref><ref id="pone.0088040-Zhu1"><text><SENT sid="1004" pm="."><plain>21 ZhuY, SpitzMR, LeiL, MillsGB, WuXF (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Research 61: 7825–7829.11691799 </plain></SENT>
</text></ref><ref id="pone.0088040-Terry1"><text><SENT sid="1005" pm="."><plain>22 TerryCF, LoukaciV, GreenFR (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. Journal of Biological Chemistry 275: 18138–18144.10747905 </plain></SENT>
</text></ref><ref id="pone.0088040-Frisdal1"><text><SENT sid="1006" pm="."><plain>23 FrisdalE, KlerkxAHEM, Le GoffW, TanckMWT, LagardeJP, et al (2005) Functional interaction between-629C/A,-971G/A and-1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. Human Molecular Genetics 14: 2607–2618.16049032 </plain></SENT>
</text></ref><ref id="pone.0088040-Pearce1"><text><SENT sid="1007" pm="."><plain>24 PearceEG, LaxtonRC, PereiraAC, YeS (2007) Haplotype effects on matrix metalloproteinase-1 gene promoter activity in cancer cells. Molecular Cancer Research 5: 221–227.17339606 </plain></SENT>
</text></ref><ref id="pone.0088040-Inoue1"><text><SENT sid="1008" pm="."><plain>25 InoueT, YashiroM, NishimuraS, MaedaK, SawadaT, et al (1999) Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. International Journal of Molecular Medicine 4: 73–77.10373641 </plain></SENT>
</text></ref><ref id="pone.0088040-Zhu2"><text><SENT sid="1009" pm="."><plain>26 ZhuY, SpitzMR, LeiL, MillsGB, WuX (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61: 7825–7829.11691799 </plain></SENT>
</text></ref><ref id="pone.0088040-Purcell1"><text><SENT sid="1010" pm="."><plain>27 PurcellS, NealeB, Todd-BrownK, ThomasL, FerreiraMA, et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. American journal of human genetics 81: 559–575.17701901 </plain></SENT>
</text></ref><ref id="pone.0088040-Barrett1"><text><SENT sid="1011" pm="."><plain>28 BarrettJC, FryB, MallerJ, DalyMJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263–265.15297300 </plain></SENT>
</text></ref><ref id="pone.0088040-Schlesselman1"><text><SENT sid="1012" pm="."><plain>29Schlesselman JJ (1982) Equation 6.9 and 6.10: Study Power with an Unequal Case-Control Ratio. </plain></SENT>
<SENT sid="1013" pm="."><plain>Case-Control Studies: Design, Conduct, Analysis. </plain></SENT>
<SENT sid="1014" pm="."><plain>USA: Oxford University Press Inc. </plain></SENT>
<SENT sid="1015" pm="."><plain>150–152. </plain></SENT>
</text></ref><ref id="pone.0088040-Matsumura1"><text><SENT sid="1016" pm="."><plain>30 MatsumuraS, OueN, KitadaiY, ChayamaK, YoshidaK, et al (2004) A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J Cancer Res Clin Oncol 130: 259–265.14986114 </plain></SENT>
</text></ref><ref id="pone.0088040-Albayrak1"><text><SENT sid="1017" pm="."><plain>31 AlbayrakS, CanguvenO, GoktasC, AydemirH, KoksalV (2007) Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population. Urol Int 79: 312–315.18025848 </plain></SENT>
</text></ref><ref id="pone.0088040-Gabriel1"><text><SENT sid="1018" pm="."><plain>32 GabrielSB, SchaffnerSF, NguyenH, MooreJM, RoyJ, et al (2002) The structure of haplotype blocks in the human genome. Science 296: 2225–2229.12029063 </plain></SENT>
</text></ref><ref id="pone.0088040-Ye1"><text><SENT sid="1019" pm="."><plain>33 YeS, ErikssonP, HamstenA, KurkinenM, HumphriesSE, et al (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. Journal of Biological Chemistry 271: 13055–13060.8662692 </plain></SENT>
</text></ref><ref id="pone.0088040-Ye2"><text><SENT sid="1020" pm="."><plain>34 YeS, DhillonS, TurnerSJ, BatemanAC, TheakerJM, et al (2001) Invasiveness of cutaneous malignant melanoma is influenced by Matrix Metalloproteinase 1 gene polymorphism. Cancer Research 61: 1296–1298.11245423 </plain></SENT>
</text></ref><ref id="pone.0088040-Miao1"><text><SENT sid="1021" pm="."><plain>35 MiaoXP, XingDY, TanW, QiJ, LuWF, et al (2002) Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk chinese population. Cancer Epidemiology Biomarkers &amp; Prevention 11: 1454–1458. </plain></SENT>
</text></ref><ref id="pone.0088040-Zhang1"><text><SENT sid="1022" pm="."><plain>36 ZhangJH, LiY, WangR, GeddertH, GuoW, et al (2003) NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World Journal of Gastroenterology 9: 1390–1393.12854127 </plain></SENT>
</text></ref><ref id="pone.0088040-Zhang2"><text><SENT sid="1023" pm="."><plain>37 ZhangJH, LiY, WangR, WenDG, SarbiaM, et al (2003) Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. International Journal of Cancer 105: 281–284.12673692 </plain></SENT>
</text></ref><ref id="pone.0088040-Fong1"><text><SENT sid="1024" pm="."><plain>38 FongYC, DuttonCM, ChaSS, GaramszegiN, SimFH, et al (2004) Absence of a correlation between the presence of a single nucleotide polymorphism in the matrix metalloproteinase 1 promoter and outcome in patients of chondrosarcoma. Clinical Cancer Research 10: 7329–7334.15534109 </plain></SENT>
</text></ref><ref id="pone.0088040-Benbow1"><text><SENT sid="1025" pm="."><plain>39 BenbowU, TowerGB, WyattCA, ButticeG, BrinckerhoffCE (2002) High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells. Journal of Cellular Biochemistry 86: 307–319.12112000 </plain></SENT>
</text></ref><ref id="pone.0088040-Jin1"><text><SENT sid="1026" pm="."><plain>40 JinX, KuangG, WeiLZ, LiY, WangR, et al (2005) No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China. World Journal of Gastroenterology 11: 2385–2389.15832405 </plain></SENT>
</text></ref><ref id="pone.0088040-Fang1"><text><SENT sid="1027" pm="."><plain>41 FangSM, JinX, WangR, LiY, GuoW, et al (2005) Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 26: 481–486.15528217 </plain></SENT>
</text></ref><ref id="pone.0088040-Przybylowska1"><text><SENT sid="1028" pm="."><plain>42 PrzybylowskaK, ZielinskaJ, ZadroznyM, KrawczykT, KuligA, et al (2004) An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer. Journal of Experimental &amp; Clinical Cancer Research 23: 121–125.15149160 </plain></SENT>
</text></ref><ref id="pone.0088040-Woo1"><text><SENT sid="1029" pm="."><plain>43 WooM, ParkK, NamJ, KimJC (2007) Clinical implications of matrix metalloproteinase-1,-3,-7,-9,-12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. Journal of Gastroenterology and Hepatology 22: 1064–1070.17608852 </plain></SENT>
</text></ref><ref id="pone.0088040-Singer1"><text><SENT sid="1030" pm="."><plain>44 SingerCF, MarbaixE, KokorineI, LemoineP, DonnezJ, et al (1997) Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1alpha and its dual block by ovarian steroids. Proceedings of the National Academy of Sciences of the United States of America 94: 10341–10345.9294212 </plain></SENT>
</text></ref><ref id="pone.0088040-Ito1"><text><SENT sid="1031" pm="."><plain>45 ItoR, KitadaiY, KyoE, YokozakiH, YasuiW, et al (1993) Interleukin-1-Alpha Acts as an Autocrine Growth Stimulator for Human Gastric-Carcinoma Cells. Cancer Research 53: 4102–4106.8358739 </plain></SENT>
</text></ref><ref id="pone.0088040-Tomimatsu1"><text><SENT sid="1032" pm="."><plain>46 TomimatsuS, IchikuraT, MochizukiH (2001) Significant correlation between expression of interleukin-la and liver metastasis in gastric carcinoma. Cancer 91: 1272–1276.11283926 </plain></SENT>
</text></ref><ref id="pone.0088040-Wyatt1"><text><SENT sid="1033" pm="."><plain>47 WyattCA, CoonCI, GibsonJJ, BrinckerhoffCE (2002) Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells. Cancer Research 62: 7200–7202.12499258 </plain></SENT>
</text></ref><ref id="pone.0088040-Ito2"><text><SENT sid="1034" pm="."><plain>48 ItoT, NakayamaT, ItoM, NaitoS, KanematsuT, et al (1998) Expression of the ets-1 proto-oncogene in human pancreatic carcinoma. Modern Pathology 11: 209–215.9504693 </plain></SENT>
</text></ref><ref id="pone.0088040-Nakayama1"><text><SENT sid="1035" pm="."><plain>49 NakayamaT, ItoM, OhtsuruA, NaitoS, NakashimaM, et al (1999) Expression of the ets-1 proto-oncogene in human thyroid tumor. Modern Pathology 12: 61–68.9950164 </plain></SENT>
</text></ref><ref id="pone.0088040-Pearce2"><text><SENT sid="1036" pm="."><plain>50 PearceE, TregouetDA, SamnegardA, MorganAR, CoxC, et al (2005) Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circulation Research 97: 1070–1076.16210545 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
